TABLE 1.
Vaccine | Serotype | n | MLTa obtained by:
|
|||||
---|---|---|---|---|---|---|---|---|
Flow assay
|
Killing assay
|
ELISA
|
||||||
Pre | Post | Pre | Post | Pre | Post | |||
23-valent PS | 6A | 23 | NDb | 0.21 | ND | 2.41 | ND | 2.30 |
6B | 23 | ND | 0.37 | ND | 2.77 | ND | 1.15 | |
19F | 23 | ND | 0.83 | ND | 2.64 | ND | 1.13 | |
Bivalent conjugate | 23F | 46c | 0.25 | 1.32 | 0.23 | 2.53 | 0.52 | 2.12 |
Tetravalent conjugate | 6B | 34 | 0.25 | 1.07 | 1.28 | 3.50 | 0.27 | 1.31 |
19F | 40 | 0.29 | 0.34 | 0.92 | 2.63 | 0.39 | 1.59 | |
23F | 40 | 0.21 | 0.62 | 0.88 | 2.85 | 0.33 | 1.54 |
Mean log10 titers (MLT) were calculated before vaccination (Pre) for conjugate antisera only and after vaccination (Post) for both PS and conjugate vaccine antisera.
ND, not done, because antisera were not available.
MLT for the killing assay was calculated for seven prevaccination and seven postvaccination antisera.